1. Nathan, N., et al., Interstitial lung diseases in children. Presse Med, 2020. 49(2): p. 103909.
2. Clement, A., et al., Interstitial lung diseases in children. Orphanet J Rare Dis, 2010. 5: p. 22.
3. Vorbroker, D.K., et al., Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am J Physiol, 1995. 268(4 Pt 1): p. L647-56.
4. Nogee, L.M., et al., A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med, 2001. 344(8): p. 573-9.
5. Baekvad-Hansen, M., et al., Two novel mutations in surfactant protein-C, lung function and obstructive lung disease. Respir Med, 2010. 104(3): p. 418-25.
6. Thomas, A.Q., et al., Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med, 2002. 165(9): p. 1322-8.
7. Soraisham, A.S., A.J. Tierney, and H.J. Amin, Neonatal respiratory failure associated with mutation in the surfactant protein C gene. J Perinatol, 2006. 26(1): p. 67-70..
8. Cameron, H.S., et al., A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr, 2005. 146(3): p. 370-5.
9. Nogee, L.M., Interstitial lung disease in newborns. Semin Fetal Neonatal Med, 2017. 22(4): p. 227-233.
10. Kurland, G., et al., An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med, 2013. 188(3): p. 376-94.
11. Gu, R., et al., Combined mutations of NKX2-1 and surfactant protein C genes for refractory low oxyhemoglobin saturation and interstitial pneumonia: A case report. Medicine (Baltimore), 2020. 99(12): p. e19650.
12. Deutsch, G.H., et al., Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med, 2007. 176(11): p. 1120-8.
13. Guillot, L., et al., New surfactant protein C gene mutations associated with diffuse lung disease. J Med Genet, 2009. 46(7): p. 490-4.
14. Thouvenin, G., et al., Characteristics of disorders associated with genetic mutations of surfactant protein C. Arch Dis Child, 2010. 95(6): p. 449-54.
15. Turcu, S., et al., Genetic testing in children with surfactant dysfunction. Arch Dis Child, 2013. 98(7): p. 490-5.
16. Nogee, L.M., Genetic Basis of Children's Interstitial Lung Disease. Pediatr Allergy Immunol Pulmonol, 2010. 23(1): p. 15-24.
17. Abou Taam, R., et al., Familial interstitial disease with I73T mutation: A mid- and long-term study. Pediatr Pulmonol, 2009. 44(2): p. 167-75.
18. Avital, A., et al., Natural history of five children with surfactant protein C mutations and interstitial lung disease. Pediatr Pulmonol, 2014. 49(11): p. 1097-105.
19. Kröner, C., et al., Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients. Eur Respir J, 2015. 46(1): p. 197-206.
20. Fortmann, C., et al., Diagnostic accuracy and therapeutic relevance of thoracoscopic lung biopsies in children. Pediatr Pulmonol, 2018. 53(7): p. 948-953.
21. Glasser, S.W., et al., Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol, 2009. 297(1): p. L64-72.
22. Glasser, S.W., et al., Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury. Respir Res, 2013. 14(1): p. 19.
23. Gupta, A. and S.L. Zheng, Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate. Arch Dis Child, 2017. 102(1): p. 84-90.
24. Rabach, I., et al., Is treatment with hydroxychloroquine effective in surfactant protein C deficiency? Arch Bronconeumol, 2013. 49(5): p. 213-5.
25. Beers, M.F., Inhibition of cellular processing of surfactant protein C by drugs affecting intracellular pH gradients. J Biol Chem, 1996. 271(24): p. 14361-70.